FDA Inspection 1030110 — SPI Pharma, Inc.
The FDA completed an inspection of SPI Pharma, Inc. on September 28, 2017 in Lewes, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 28, 2017
- Fiscal Year
- 2017
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Lewes, DE (United States)